Stason Pharmaceuticals, Inc. recalls Mercaptopurine Tablets
FDA Class III
FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).
- Hazard
- Failed Dissolution Specifications: results slightly under spec at at 9-months.
- Products
-
- Mercaptopurine Tablets
- Company
- Stason Pharmaceuticals, Inc.
- Where it was sold
-
USA Nationwide
Nationwide
- Units affected
- 54, 131 bottles
- About this recall
- Mercaptopurine Tablets, USP 50 mg, packaged in: a) 25-count bottle (NDC 69076-913-02), b) 250-count bottle (NDC 69076-913-25), Rx only, Manufactured for: Quinn Pharmaceuticals, Boca Raton, FL, www.quinnrx.com